http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113116875-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166 |
| filingDate | 2021-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113116875-B |
| titleOfInvention | Use of SD49-7 in the preparation of medicines for treating leukemia |
| abstract | The invention relates to the field of medicine, in particular to the use of SD49-7 in the preparation of medicines for treating leukemia. The KDM4 small molecule inhibitor SD49-7 of the present invention has a good inhibitory effect on human leukemia drug-resistant cell lines and human leukemia stem progenitor cells, and can provide a new method for future clinical treatment. |
| priorityDate | 2021-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.